Manufacturer record
Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 were declared Not of Standard Quality between May 2025 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Samarth Pharmaceuticals Office No. 201 GIDC Shopping Centre Morarji Circle GIDC Vapi-396195 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| White Powder Paracetamol IP | PAR040325Mfg 2025-03 · Exp 2030-02 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab | May 2025 |
| White Powder Paracetamol IP | PAR050325Mfg 2025-03 · Exp 2030-02 | Identification Test Found To be Negative. Assay of Paracetamol IP-NILAssay | State Food & Drug Testing Laboratory UttarakhandState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.